ERBB2 and breast cancer: Triple negative breast cancer (TNBC) which is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (Her-2) accounts for 10–20% of all breast cancer.